Investigators isolated nuclei from frozen parietal-cortex tissue and used fluorescence-activated cell sorting to enrich NeuN-positive neuronal populations. Two sorting rounds produced samples in which more than 70% of nuclei were tetraploid, although one Alzheimer’s sample was discarded because it did not meet that threshold. Researchers then extracted genomic DNA from 430 to 550 neuronal nuclei per sample and amplified it with PicoPLEX before preparing exome libraries for sequencing. The resulting reads were aligned to the human reference genome, and SNVs and INDELs were called with VarScan 2 and LoFreq. Variants were classified as germline or somatic primarily by allele frequency: a threshold of 0.25 separated the low-frequency population interpreted as somatic from the predominantly germline variants at higher frequencies.

The rise in mutations was highly specific to single-base changes. Overall, Alzheimer’s-derived tetraploid neurons contained 16% more mutations than diploid neurons from the same patients, with the difference attributable to a 17% increase in sSNVs. Somatic INDEL counts were similar in tetraploid Alzheimer’s neurons, diploid Alzheimer’s neurons and control neurons. A second analysis with LoFreq, which can identify variants occurring at frequencies as low as roughly 0.05% to 1%, again found significantly more sSNVs in tetraploid cells. Most were concentrated at allele frequencies of 0.005 to 0.03, with a pronounced peak at 0.01, whereas diploid neurons had a flatter distribution. In the broader analysis, the proportion of somatic variants rose by 45% in tetraploid neurons relative to control neurons.

Mutation type provided another striking clue. Tetraploid neurons were strongly enriched for thymine-to-cytosine transitions, written T>C, which are equivalent to adenine-to-guanine changes on the complementary DNA strand. This class accounted for roughly 64% of variants unique to tetraploid neurons, compared with about 37% of variants shared by diploid and tetraploid populations and 34% of variants unique to diploid neurons. Such transitions have been associated with oxidative DNA damage, including damage linked to lipid peroxidation. The T>C enrichment was also concentrated among variants below an allele frequency of 0.05, indicating that it was especially pronounced in the ultra-low-frequency population enriched in Alzheimer’s tetraploid cells.

The authors also compared the variant profiles with established single-base substitution signatures derived from large cancer-sequencing datasets. SBS123 made the largest contribution in most samples, but its relative share was higher in the tetraploid Alzheimer’s group, reaching 64% to 66% of fitted mutations, compared with 49% to 57% in controls and 52% to 59% in diploid Alzheimer’s neurons. The two tetraploid samples also shared a secondary combination of SBS116 and SBS5 that was not consistently present in the diploid groups. Cosine similarities between observed and reconstructed spectra ranged from 0.938 to 0.958. These analyses support a shift in the mixture of mutational processes associated with tetraploidy, rather than the appearance of a wholly tetraploid-specific signature.

Gene-level analysis showed that Alzheimer’s tetraploid neurons accumulated especially many sSNVs in pathways governing oxidative stress and DNA repair. Total SNVs increased by 38% in genes associated with antioxidant activity, 31% in genes involved in the response to reactive oxygen species, 29% in genes linked to hydrogen peroxide activity and 26% in genes associated with oxidative stress. Somatic variants in antioxidant and reactive-oxygen-response genes increased by 64% and 61%, respectively, both larger than the 45% genome-wide rise. Among DNA-repair genes, total SNVs increased by 31% and sSNVs by 64% in tetraploid cells. Base-excision, mismatch and nucleotide-excision repair genes showed significant sSNV increases, whereas double-strand-break-repair genes did not.

Not every disease-related category behaved as expected. Somatic variants also accumulated in genes associated with Parkinson’s disease, including a 64% increase over the genome-wide value, while sSNVs in Alzheimer’s risk genes rose by 59%. The pattern varied among individual genes, with significant increases in ABCA7, APOE, BIN1, CD33, EPHA1, MAPT, PSEN2, SMARCA4 and PLD3, but decreases in CD2AP and PSEN1. The study therefore found no simple, exclusive association between mutations in Alzheimer’s genes and the tetraploid state. A computational molecular pathogenicity analysis instead suggested that the mutations affecting genes in cancer and senescence pathways were more likely than random variants to be predicted to damage protein function.

That pathogenicity analysis used a score ranging from zero for the least pathogenic prediction to five for the most pathogenic and combined outputs from 12 computational tools. Cancer-related and senescence-related sSNVs had significantly steeper score distributions than generic genes, as did variants in several oxidative-stress and DNA-repair categories. Alzheimer’s and Parkinson’s risk genes did not show higher scores than control genes. These are computational predictions, not measurements of protein activity. The study did not perform functional assays, matched RNA sequencing or targeted validation of individual variants, so the data cannot establish that the mutations impaired DNA repair, altered gene expression or drove cell-cycle re-entry.

A central technical concern is that the neuronal DNA underwent whole-genome amplification before sequencing. PicoPLEX can introduce allelic imbalance, allelic or locus dropout and polymerase-derived errors, all of which may alter the frequencies used to distinguish somatic from germline variants. The distinct T>C spectrum in tetraploid-specific variants and its resemblance to independently established mutational signatures argue against a uniform amplification bias fully explaining the population-level pattern. They do not, however, rule out stochastic errors affecting individual low-frequency calls. The investigators also used a non-parametric bootstrap with 5,000 resamples to assess uncertainty in group means and pairwise differences; its confidence intervals were consistent with the original parametric analyses, but it did not increase the study’s effective sample size or statistical power.

The results are compatible with a self-reinforcing model of Alzheimer’s-associated neuronal tetraploidy. Oxidative stress could damage DNA, including genes involved in antioxidant responses and DNA repair; mutations in those genes could then impair genome maintenance and favor aberrant cell-cycle activity and genome duplication. Once tetraploidy was established, increased genomic stress could further elevate somatic mutation burden. Conversely, severe Alzheimer’s pathology could cause cellular stress and genome instability in already-tetraploid neurons, producing the same pattern. Because all three Alzheimer’s brains were at Braak stage V/VI and no early or mild cases were examined, the cross-sectional data cannot determine temporal order or causality. The clearest conclusion is therefore that Alzheimer’s-associated tetraploid neurons carry a specific enrichment of sSNVs with an oxidative-associated T>C pattern, particularly in oxidative-stress and DNA-repair genes, that merits validation in larger cohorts and with sequencing methods capable of confirming rare variants without amplification.

Subject of Research: Somatic single nucleotide variants in Alzheimer’s-associated tetraploid neurons

Article Title: Specific enrichment of somatic single nucleotide variants in Alzheimer-associated tetraploid neurons

Article References: López-Sánchez, N., Rábano, A., & Frade, J. M. (2026). Specific enrichment of somatic single nucleotide variants in Alzheimer-associated tetraploid neurons. Frontiers in Molecular Neuroscience, 19, Article 1929505. https://doi.org/10.3389/fnmol.2026.1929505

Image Credits: AI Generated

DOI: 10.3389/fnmol.2026.1929505

Keywords: Alzheimer’s disease, neuronal tetraploidy, somatic mutations, single nucleotide variants, whole-exome sequencing, oxidative stress, DNA repair, mutational signatures, post-mortem brain, genome instability, Specific, enrichment

The analysis assessed two error-prone pathways that generally serve as backup mechanisms when DNA double-strand breaks cannot be repaired through homologous recombination. Deletion patterns are described as “putative” scars, meaning that the genomic analysis was used to infer association with these repair processes rather than directly measuring pathway activity. The study’s purpose was to determine how extensively such patterns occur across tumor types and whether they are linked solely to homologous-recombination deficiency.

Although Alt-EJ-associated deletion burdens were generally higher in homologous-recombination-deficient tumors, the pattern varied by cancer type. Prostate adenocarcinoma and hepatocellular carcinoma had elevated numbers of SSA-associated deletions despite low homologous-recombination-deficiency scores. The researchers also found that SSA-associated deletions were more frequent in SINE-rich genomic regions. Among homologous-recombination-proficient lymphoid lineage tumors, these deletions showed pronounced enrichment near transcription start sites. Together, the reported results suggest that the genomic context of the deletion was associated with different dimensions of DNA-break repair activity beyond homologous-recombination deficiency alone.

The findings are based on the supplied abstract of an open-access BMC Cancer research article; the full study methods and results were not available for independent assessment. The deletions are therefore presented as putative pathway-associated signatures, and the abstract does not establish that the patterns directly quantify repair-pathway engagement. The publisher also states that the accessible article is an early version of peer-reviewed, accepted research, carries a permanent DOI, and may undergo further editorial revision before the final version of record.

Subject of Research: Genome-wide analysis of deletion patterns associated with SSA and alternative end joining across 17 cancer types

Article Title: Pan-cancer genomic scars of alternative end joining and single-strand annealing

Article References: Modi, A., Zito, A., & Parmigiani, G. (2026). Pan-cancer genomic scars of alternative end joining and single-strand annealing. BMC Cancer. https://doi.org/10.1186/s12885-026-16895-2

Image Credits: AI Generated

DOI: 10.1186/s12885-026-16895-2

Keywords: cancer genomics, DNA repair, homologous recombination, single-strand annealing, alternative end joining, genome instability, tumor deletions, pan-cancer analysis, Pan-cancer, genomic, scars, alternative

The team’s central question was deceptively simple: can the merger of two genetically identical, non-malignant cells set in motion the kind of genome-wide upheaval that is normally associated with tumor initiation? The answer, documented across karyotypic, morphological, transcriptomic and phenotypic analyses, is a resounding yes. The researchers labeled the nuclei of M13SV1 human breast epithelial cells with two different fluorescent histone tags, H2B-GFP and H2B-mCherry, and co-cultured the two populations. Any cell that spontaneously fused would carry both colors in its nucleus, allowing the team to pick out and propagate individual hybrid clones derived from nothing more than unscheduled fusion between healthy cells.

Flow cytometry revealed that these hybrids began life near-tetraploid, carrying roughly double the normal complement of chromosomes, and were already saturated with DNA damage. Using the γ-H2AX marker, which flags double-strand breaks, the researchers found that up to ten percent of cells in the hybrid populations displayed damage foci, concentrated overwhelmingly in the S and M phases of the cell cycle. This is a crucial detail: it suggests that most of the damage arises during DNA replication and is carried straight into mitosis without repair. When the team visualized dividing hybrid cells under a confocal laser-scanning microscope, they saw a gallery of mitotic horrors, including multipolar spindles, lagging chromosomes and extrachromosomal DNA, with γ-H2AX foci present in every dividing cell examined.

Whole-genome doubling is far from a rare curiosity in human cancer. Pan-cancer genome studies indicate that approximately 30 to 37 percent of cancer cells within solid tumors carry a tetraploid karyotype resulting from a whole-genome doubling event, which can arise through endocycling, mitotic slippage, endomitosis, cytokinesis failure or cell fusion. Cells with more than two chromosome sets are predisposed to chromosomal instability because extra centrosomes and oversized genomes create fertile ground for segregation errors. Merotelic kinetochore attachments, in which microtubules from opposing spindle poles compete for the same chromosome, produce lagging chromosomes that become trapped in the cleavage furrow and eventually form their own micronuclei. Because micronuclei possess defective nuclear laminae, the DNA inside them suffers strand breaks and large-scale rearrangements, a process that can culminate in chromothripsis, the shattering and random reassembly of entire chromosomes.

Perhaps the most provocative finding of the new study concerns what happened when the hybrid clones were passaged over the long term. Between early passages (4 to 6) and late passages (20 to 22), all three hybrid clones underwent a ploidy reduction, shifting from near-tetraploid to near-triploid or, in one case, a mixed near-triploid and near-diploid state. Crucially, this reduction in genome size was not accompanied by any reduction in DNA damage. The burden of lesions remained constant or even increased, and the heaviest damage continued to accumulate during replication and mitosis. The researchers interpret this as evidence of ploidy-dependent replication stress: a doubled genome demands nucleotides and replication factors that the cell cannot supply in proportion, causing replication forks to stall and collapse, and generating the double-strand breaks that fuel ongoing chromosomal instability.

Single-cell fate tracking painted an equally dramatic picture. Compared with diploid parental cells, in which roughly one fifth of divisions went awry and most aberrant progeny promptly died, the hybrid clones exhibited aberrant mitotic outcomes in 40 to 60 percent of tracked divisions. These included multipolar division, endoreplication, failed cytokinesis and even refusion, in which daughter cells merged back together after mitosis. The hybrids also survived these errors far more successfully than their diploid parents, a resilience the authors attribute to their extra chromosome copies, which buffer against the lethal loss of essential genes. Over time, the hybrid populations even regained proliferative capacity, with late-passage clones outgrowing the parental cells, suggesting that an ongoing post-hybrid selection process was actively favoring faster-growing subclones.

Morphometric analysis added another layer of intrigue. Early-passage hybrids were enlarged by only 15 to 40 percent in cell area despite carrying roughly double the DNA, and their nuclei were 20 to 60 percent larger than those of diploid controls. As passages accumulated and ploidy fell, both cell and nuclear size shrank in a hybrid-clone-dependent manner, with one clone’s cell area returning almost exactly to the diploid baseline even as its nucleus remained enlarged. The team also documented a striking degree of nuclear deformation, with multi-lobulation, invagination and nuclear blebbing persisting across all passages. A Pearson correlation analysis revealed that the degree of nuclear deformation was positively correlated with the amount of DNA damage, particularly during the S and M phases, supporting the idea that a distorted nuclear architecture and genomic instability reinforce one another in a vicious cycle.

Transcriptomic profiling by RNA sequencing exposed the malignant potential simmering beneath this chromosomal chaos. All three hybrid clones shared 427 differentially expressed genes relative to the parental cells, and enrichment analysis showed that genes linked to epithelial-mesenchymal transition, or EMT, hypoxia, p53 signaling and xenobiotic metabolism were consistently upregulated. Western blots confirmed that the hybrids had lost the epithelial marker E-cadherin in two clones and gained the mesenchymal markers N-cadherin and vimentin, hallmarks of a phenotypic switch toward motility and invasiveness. Functional assays backed this up: hybrid clones formed more colonies and larger mammospheres than parental cells, and two clones showed markedly enhanced migratory and invasive behavior. Notably, EMT gene expression was enriched only in late-passage hybrids, suggesting that the mesenchymal switch is a subclonal evolutionary process rather than an immediate consequence of fusion.

One chromosomal region stood out in the transcriptional mapping. The p36 locus on chromosome 1 was significantly downregulated in every hybrid clone, and within the 1p36.33 to 1p36.31 segment, the tumor suppressor gene AJAP1 was the most heavily silenced, with log2 fold changes ranging from minus six to minus ten. This is a finding with clear clinical resonance. Deletion of 1p36 is a common event across many cancer types, and analysis of the TCGA pan-cancer dataset showed that copy number loss of this region is associated with worse overall survival. AJAP1 expression was lower in tumor tissue than in healthy tissue, lowest of all in metastatic lesions, and reduced AJAP1 levels correlated with higher patient mortality. Because AJAP1 is known to inhibit EMT, its near-complete loss in the hybrids fits neatly with their mesenchymal, migratory phenotype.

Taken together, the study frames atypical cell fusion as a potential catastrophic event in carcinogenesis, comparable in its genomic consequences to chromothripsis or chromoplexy, which pan-cancer analyses have detected in more than a fifth of tumors. A single fusion event instantly doubles the genome, disrupts the cytoplasm, duplicates centrosomes and forces the hybrid cell through a first mitosis in which parental genomes collide, unleashing genome chaos at a macroevolutionary pace. The surviving hybrids, buffered by their extra chromosomes and shaped by relentless selection, drift toward smaller, faster-growing, more motile subclones with premalignant transcriptional signatures. While the researchers caution that further work, including limited-dilution and transplantation experiments, is needed to confirm true tumor-initiating capacity, the message is clear: the road to cancer may sometimes begin not with a mutation in a single gene, but with two healthy cells making the fateful decision to become one.

Subject of Research: Spontaneous fusion of non-transformed breast epithelial cells inducing genome chaos, chromosomal instability and premalignant hybrid phenotypes

Article Title: Atypical fusion among non-malignant cells: Unveiling the link between post-fusion-induced genome chaos and cancer initiation

Article References: Weiler, J., Topsis, G. R., & Dittmar, T. (2026). Atypical fusion among non-malignant cells: Unveiling the link between post-fusion-induced genome chaos and cancer initiation. Cancer Cell International, 26(1), Article 338. https://doi.org/10.1186/s12935-026-04466-1

Image Credits: AI Generated

DOI: 10.1186/s12935-026-04466-1

Keywords: cell fusion, genome chaos, chromosomal instability, polyploidy, whole-genome doubling, breast epithelial cells, EMT, micronuclei, AJAP1, 1p36 deletion, cancer initiation, hybrid cells

BRCA2 is best known as a guardian of the genome. The protein it encodes is essential for homologous recombination, the high-fidelity repair mechanism cells use to mend dangerous double-strand breaks in DNA. But BRCA2 does more than patch breaks. It also stabilizes stalled replication forks, the Y-shaped structures that unzip the double helix so each strand can be copied, and it suppresses the accumulation of single-stranded DNA gaps that arise when replication runs into trouble. When BRCA2 function drops, even partially, cells accumulate under-replicated DNA, and this chronic replication stress creates a permissive environment for cancer initiation. Crucially, breast epithelium from BRCA2 mutation carriers shows signs of functional haploinsufficiency, meaning that a single working copy of the gene is not enough to fully maintain genome stability.

The research team began by mining a publicly available single-cell RNA sequencing dataset of primary breast epithelial cells from BRCA2 mutation carriers and non-carrier controls. They examined the expression of four Y-family translesion synthesis polymerases, REV1, Pol κ, Pol η, and Pol ι, across the major epithelial compartments of the breast, including basal or myoepithelial cells, alveolar cells, and hormone-sensing luminal cells. Among all four enzymes, POLI, the gene encoding Pol ι, stood out with the most striking genotype-dependent difference. The proportion of POLI-positive hormone-sensing epithelial cells was selectively and significantly enriched in samples from BRCA2 mutation carriers, while expression of the other three polymerases remained essentially unchanged in that compartment.

To confirm that this induction was not merely a correlation, the researchers silenced BRCA2 with small interfering RNA in non-transformed MCF10A mammary epithelial cells, in primary human mammary epithelial cells, and in MCF7 breast cancer cells. In every model, BRCA2 depletion produced a marked increase in nuclear Pol ι protein, detected by immunofluorescence and quantified across hundreds of individual cells. Cell-cycle profiling showed that the increase was not confined to a single phase: Pol ι fluorescence intensity rose across G1, S, and G2/M after BRCA2 knockdown. However, cells with the highest Pol ι levels were significantly enriched in G2/M, the phase immediately preceding cell division, hinting at a role for the enzyme late in the cell cycle. Analysis of primary hormone-sensing cells from BRCA2 mutation carriers reinforced this picture, revealing a greater proportion of Pol ι-high cells in S and G2/M phases, and these Pol ι-high cells carried transcriptional signatures associated with mitosis.

That timing mattered, because it pointed the investigators toward a specialized salvage pathway known as mitotic DNA synthesis, or MiDAS. When replication stress leaves stretches of DNA uncopied by the end of S phase, some cells complete the job during mitosis itself, particularly at common fragile sites, genomic regions that are intrinsically difficult to replicate. The canonical mediator of this process is RAD52, a recombination protein. To test whether Pol ι also contributes, the team depleted BRCA2, POLI, or both in MCF10A cells, applied a mild replication stress with low-dose aphidicolin, a drug that slows the replicative polymerase, and measured DNA synthesis in mitotic cells using incorporation of the nucleotide analog EdU alongside FANCD2 foci, which mark under-replicated DNA. BRCA2 depletion sharply increased both EdU incorporation and FANCD2 foci in mitotic cells, and combined BRCA2 and POLI depletion pulled both readouts back down toward control levels. POLI depletion alone had little effect in BRCA2-proficient cells, and the reduction achieved by removing Pol ι was comparable to that achieved by removing RAD52, although RAD52 produced a somewhat stronger overall effect.

Then came the surprise. Post-S-phase DNA synthesis is generally regarded as protective, a last-ditch mechanism that prevents under-replicated DNA from being dragged into mitosis and causing chromosome breakage. If Pol ι were performing that protective function, removing it should have made BRCA2-deficient cells even more genomically unstable. Instead, the opposite happened. When the team quantified 53BP1 nuclear bodies, well-established markers of under-replicated DNA that persist into the next G1 phase, combined BRCA2 and POLI depletion did not increase their formation and in fact trended toward fewer nuclear bodies than BRCA2 depletion alone. Micronucleus assays, which detect chromosome fragments that fail to segregate properly, told the same story, and metaphase spreads revealed a modest but statistically significant reduction in chromosome gaps and breaks at fragile sites when POLI was removed from BRCA2-deficient cells. In primary mammary epithelial cells from a BRCA2 mutation carrier, POLI depletion under mild replication stress significantly reduced levels of γH2AX, a marker of DNA damage signaling, and combined depletion also lowered RPA32, a marker of single-stranded DNA accumulation.

The resolution to this paradox came from DNA fiber assays, which track the progress of individual replication forks in living cells. The researchers sequentially labeled newly synthesized DNA with two distinguishable nucleotide analogs, CIdU for a short pulse and IdU for an extended pulse, in the presence of aphidicolin, and measured the ratio of tract lengths as a readout of fork speed. BRCA2 depletion increased the IdU/CIdU ratio, and combined BRCA2 and POLI depletion pushed fork progression even higher, indicating that loss of Pol ι actually helps replication forks move faster through stressed BRCA2-deficient genomes. Parallel untreated controls confirmed the effect was specific to replication stress. In other words, removing Pol ι appears to partially alleviate the very stress it was recruited to tolerate, suggesting that Pol ι-dependent DNA synthesis may itself impose a burden, or that compensatory synthesis pathways take over when Pol ι is absent. The precise molecular mechanism linking fork dynamics to post-S-phase synthesis remains an open question the authors flag for future work.

The study also connected these replication-level changes to epithelial cell identity, a link with direct relevance to early tumor evolution. Preneoplastic breast tissue from BRCA mutation carriers is known to show expansion of luminal epithelial populations, and the team’s own single-cell analysis had highlighted hormone-sensing luminal cells as the site of POLI induction. Using flow cytometry for EpCAM, a pan-epithelial marker, and CD24, a marker associated with luminal identity, the researchers found that both BRCA2 depletion and POLI depletion expanded the EpCAM-high/CD24-high population in MCF10A cells. POLI depletion produced the larger expansion, and the two depletions were not additive, indicating that Pol ι-dependent and Pol ι-independent adaptive pathways both feed into this luminal-like cell state. Prior studies have associated CD24-high epithelial states with adaptive stress responses in several biological contexts, lending plausibility to the idea that replication stress processing and epithelial state remodeling are intertwined.

The authors are careful to delineate what their data do and do not establish. The functional experiments relied on transient siRNA silencing, which captures acute responses but cannot speak to the consequences of sustained POLI alteration over longer timescales. The EdU-based assay detects DNA synthesis across the G2/M boundary but cannot distinguish canonical mitotic DNA synthesis from persistent G2-phase synthesis or S-to-M runover, which is why the team refers collectively to post-S-phase DNA synthesis. And while POLI depletion was associated with both altered replication stress responses and expansion of a luminal-like population, the study does not prove a causal relationship between the two phenotypes. The upstream mechanisms that drive POLI upregulation in BRCA2-deficient cells, and the pathways through which Pol ι influences fork dynamics, also remain to be defined.

Even with those caveats, the work delivers a compelling conceptual advance. It positions Pol ι not as a universal replication factor but as a context-dependent regulator whose importance emerges specifically under BRCA2-associated replication stress, and it ties together three threads, post-S-phase DNA synthesis, fork progression, and epithelial cell state, into a single framework for the earliest stages of BRCA2-associated breast tumorigenesis. If the adaptive, Pol ι-coordinated response to chronic replication stress helps shape the preneoplastic epithelium of mutation carriers, then interfering with that response, or understanding which cells it favors, could eventually inform prevention strategies aimed at the window before cancer takes hold. For now, the study offers a vivid reminder that the road to cancer in BRCA2 carriers may begin not with a catastrophic break, but with the quiet recruitment of an error-prone polymerase to unfinished DNA.

Subject of Research: The role of polymerase iota in replication stress adaptation in BRCA2-deficient mammary epithelial cells

Article Title: Polymerase iota coordinates adaptation to replication stress in BRCA2-deficient mammary epithelial cells

Article References: Vipparthi, K., Bellare, A., Ozbilgic, R., Bazeley, P., Khanna, N., Wang, F., Bhushan, A., Xie, L., Al-Hilli, Z., Zhang, Y.-W., & Karaayvaz, M. (2026). Polymerase iota coordinates adaptation to replication stress in BRCA2-deficient mammary epithelial cells. iScience, 29(11), Article 117830. https://doi.org/10.1016/j.isci.2026.117830

Image Credits: AI Generated

DOI: 10.1016/j.isci.2026.117830

Keywords: BRCA2, polymerase iota, replication stress, mitotic DNA synthesis, mammary epithelial cells, translesion synthesis, genome instability, common fragile sites, luminal progenitors, breast cancer, RAD52, DNA fiber assay

The team built a diploid yeast strain in which both copies of the SOD1 gene had been deleted, creating a hybrid background containing roughly 50,000 sequence differences between its two parental genomes. This design allowed the researchers to map, with extraordinary resolution, every loss of heterozygosity event that accumulated as cells divided. After subculturing 32 independent isolates for hundreds of generations, whole-genome sequencing revealed a staggering catalogue of damage. Single nucleotide variations accumulated at 13 times the wild-type rate, loss of heterozygosity rose 12-fold, large chromosomal rearrangements increased 4-fold, and aneuploidy—the gain or loss of entire chromosomes—surged an astonishing 48-fold above normal levels.

The scale and diversity of these lesions underscored that Sod1 deficiency does not merely nudge the genome toward instability; it fundamentally rewrites the rules of genome maintenance. The researchers detected 322 interstitial and 134 terminal loss-of-heterozygosity events across their isolates, occurring at rates 15- and 16-fold higher than in wild-type cells, respectively. Gene conversion tracts—the stretches of DNA copied from one homologous chromosome to repair damage on the other—were also markedly longer in the mutant, averaging 10.8 kilobases compared with 5.9 kilobases in healthy cells. Most structural rearrangements were flanked by Ty retrotransposon sequences, pointing to unequal recombination between repetitive elements as a major driver of large-scale chromosome changes.

Perhaps the most striking result came when the researchers repeated the experiment under anaerobic conditions. Deprived of oxygen, the sod1 mutant’s genomic chaos vanished almost entirely: mutation rates fell to wild-type levels and recombination rates dropped dramatically. Supplementing the growth medium with glutathione, a potent cellular antioxidant, similarly cut mutation and recombination frequencies by more than half. Together, these experiments identified reactive oxygen species as the sole executioner behind the genomic storm, confirming that the instability arises from direct chemical attack on DNA rather than from indirect disruption of repair machinery or metabolic collapse.

The mutational fingerprint left by Sod1 loss proved highly distinctive. All six classes of base substitutions increased, but transversions dominated, particularly C:G to A:T changes concentrated within 5′-CCA-3′ sequence motifs. This pattern is the classic signature of 8-oxoguanine, an oxidized form of guanine that mispairs with adenine during replication, producing the characteristic transversion after a second round of DNA copying. The finding directly implicates 8-oxoguanine overproduction as the molecular engine of Sod1-deficient mutagenesis, and it links the enzyme’s antioxidant function to a specific, measurable chemical lesion on DNA.

Dissecting how cells cope with these lesions revealed a sophisticated hierarchy of repair and bypass. The base excision repair glycosylase Ogg1 emerged as the frontline defense: deleting OGG1 alone caused a 19-fold rise in C:G to A:T transversions, and combining OGG1 deletion with SOD1 deletion produced a synergistic 7.5-fold increase over the ogg1 mutant alone. By these calculations, Ogg1-mediated excision corrects roughly 90 percent of the 8-oxoguanine lesions generated in the absence of Sod1. When repair is overwhelmed, translesion synthesis polymerases take over, and here the outcomes diverge sharply. DNA polymerase eta, encoded by RAD30, performs relatively accurate bypass by inserting cytosine opposite the oxidized base, preventing about a third of the characteristic transversions. In contrast, the error-prone polymerase zeta and its partner Rev1 account for approximately two-thirds of all Sod1-induced point mutations, illustrating the costly trade-off between completing replication and preserving sequence fidelity.

Timing analysis of recombination events added another layer of mechanistic insight. Using a colony-sectoring assay on chromosome IV, the team showed that about 65 percent of mitotic crossovers in sod1 mutants were initiated by double-strand breaks arising during the G1 phase of the cell cycle, closely mirroring the pattern in wild-type cells. Fluorescence microscopy of Rad52 repair foci confirmed a four-fold increase in spontaneous DNA breaks. Intriguingly, the distribution of crossover breakpoints was not random: 33 of 35 events on chromosome IV clustered distal to the SSD1 locus, a bias the researchers traced to post-mutational selection rather than intrinsic recombination hotspots. Restoring a functional SSD1 allele, which improved fitness in the sod1 background, redistributed breakpoints uniformly, demonstrating that observed genomic landscapes reflect both where damage occurs and which recombinant cells survive to form colonies.

The study then turned to human disease, testing eight ALS-associated SOD1 variants in the yeast system. Wild-type human SOD1 fully rescued the growth defects and genomic instability of yeast lacking endogenous Sod1, confirming deep functional conservation. But the clinical variants were not created equal. The H48Q mutation, which disrupts a copper-binding residue essential for catalytic activity, shattered genome stability, producing 8- and 10-fold increases in mutation and recombination rates alongside severe growth impairment. The G85R and S133N variants showed moderate effects, while the well-known A4V, G36R, D90A, and G93A variants remained essentially benign in this context. These results suggest that for a subset of ALS patients, loss of genomic protection—driven by failure to quench nuclear reactive oxygen species—may constitute an additional, mutation-specific pathogenic mechanism beyond the prevailing toxic gain-of-function model of protein aggregation.

Notably, the researchers found that human Sod1 is far more tolerant of amino acid substitutions than its yeast counterpart, a difference they attribute to the extraordinary structural robustness of the human enzyme, which remains stable even in metal-deficient states. This resilience likely reflects evolutionary pressure in long-lived organisms to protect the proteome against decades of somatic mutation. The work also carries a cautionary message for cancer therapy: because tumor cells often depend on elevated Sod1 to manage their oxidative burden, pharmacological inhibition of the enzyme, while potentially cytotoxic, risks triggering a mutational burst that could accelerate the emergence of drug-resistant clones. By mapping the full genomic consequences of antioxidant failure—from single nucleotides to whole chromosomes—this study establishes a mechanistic framework for understanding how metabolic defense and genome integrity are inseparably coupled in eukaryotic life.

Subject of Research: The role of superoxide dismutase 1 in protecting eukaryotic genome stability against oxidative DNA damage

Article Title: Decoupling metabolic defense: Mutational and recombinational chaos in Sod1-deficient cells

Article References: Sui, Y., Zheng, D.-Q., Wang, Y., Zhao, S.-S., Li, K.-J., Ye, C., & Zhang, K. (2026). Decoupling metabolic defense: Mutational and recombinational chaos in Sod1-deficient cells. PLOS Genetics, 22(10), e1012326. https://doi.org/10.1371/journal.pgen.1012326

Image Credits: AI Generated

DOI: 10.1371/journal.pgen.1012326

Keywords: Sod1, genome instability, reactive oxygen species, 8-oxoguanine, yeast, loss of heterozygosity, aneuploidy, base excision repair, translesion synthesis, ALS, SOD1 mutations, oxidative stress

What has remained far murkier is how the loss of ATM reshapes the activity of microRNAs, the tiny non-coding RNA molecules that fine-tune gene expression after transcription. MicroRNAs destabilize messenger RNAs or block their translation into proteins, and in the DNA damage response they modulate repair, checkpoint control, apoptosis, senescence and cell-cycle progression. The relationship between ATM and microRNAs runs in both directions. Damage-responsive microRNAs can be transcribed under the control of p53, which itself sits downstream of ATM. ATM can directly activate microRNAs and even promote global microRNA biogenesis: a landmark study showed that ATM phosphorylates the RNA-binding protein KSRP, physically linking ATM signaling to the microRNA processing machinery. Conversely, the microRNA miR-421 can suppress ATM expression by targeting the ATM 3-prime untranslated region, experimentally producing checkpoint defects and increased radiosensitivity. This bidirectional wiring means that a cell lacking functional ATM could suffer microRNA dysregulation through multiple, overlapping mechanisms.

A new study published in Molecular Biology Reports by Muhammad Junaid Iqbal, Michele Menotta and colleagues at the University of Urbino Carlo Bo, together with collaborators in China and Pakistan, set out to characterize this interface in a controlled experimental system. Rather than attempting an unbiased biomarker screen, the team designed a mechanistically motivated assay of four predefined candidate microRNAs chosen to represent complementary arms of the ATM-associated DNA damage response and checkpoint network. miR-34a-5p was selected as the canonical p53-responsive microRNA involved in apoptosis, cell-cycle arrest and senescence, whose mature activity can also be modulated through ATM-dependent 5-prime-end phosphorylation after DNA damage. miR-26a-5p was included for its reported links to genotoxic stress and checkpoint regulation, including regulation of the kinases WEE1 and CHK1 and PTEN-AKT-associated phenotypes. miR-106b-5p and miR-20a-5p were chosen to represent the G1/S and RB/E2F checkpoint-modulatory arm, since miR-106b family members regulate the p21 cell-cycle inhibitor and miR-20a participates in c-Myc/E2F1-associated G1 checkpoint control.

The experimental design was deliberately simple and tightly controlled. The researchers compared one ATM-proficient human fibroblast control line, AG09429, with three patient-derived A-T fibroblast lines, GM00648, GM05849 and GM09607, all obtained from the Coriell Institute for Medical Research. Two of the lines were immortalized in-house by hTERT transduction, while the other two were obtained as transformed lines. To inflict controlled genotoxic stress, the team used bleomycin, a radiomimetic glycopeptide antibiotic that generates oxidative DNA lesions and strand breaks through an iron- and oxygen-dependent mechanism. Because ATM is the central transducer of double-strand break signaling, bleomycin provided a clean way to compare basal and stress-responsive microRNA behavior. Cultures were treated with 8 micrograms per milliliter of bleomycin for three hours, then allowed to recover for 24 hours before RNA extraction. Mature microRNA abundance was quantified by TaqMan reverse transcription quantitative PCR, normalized to the endogenous control miR-16-5p and analyzed with the comparative Ct method across three independent biological replicates per condition.

The basal results were striking. Under untreated conditions, miR-34a-5p showed the most pronounced difference between the control and the A-T panel: all three A-T lines displayed a highly significant reduction in miR-34a-5p compared with the untreated control, each with a p-value below 0.001 after Dunnett’s multiple-comparison testing. miR-26a-5p followed the same pattern, with significantly lower expression in all three A-T lines. miR-106b-5p showed a weaker, line-dependent profile, significantly reduced in two of the three A-T lines but not the third, while miR-20a-5p showed no significant basal differences at all. In other words, the dominant basal phenotype was a reproducible depletion of exactly the two microRNAs most directly tied to p53 signaling and checkpoint regulation, a pattern biologically coherent with impaired ATM-p53 signaling in these cells.

After bleomycin exposure, the between-line differences persisted. miR-34a-5p and miR-26a-5p remained significantly lower in all three bleomycin-treated A-T lines relative to the single bleomycin-treated control, again with p-values below 0.001. Meanwhile, miR-106b-5p and miR-20a-5p behaved in a more condition-dependent manner, with the strongest divergence seen in the AT648 line, which showed significantly higher expression of both microRNAs than the treated control. Crucially, the researchers separated between-line differences from acute treatment responses by performing paired within-line analyses. In the control fibroblasts, bleomycin significantly induced miR-34a-5p and reduced miR-106b-5p, a selective stress response rather than broad induction of the whole panel. AT648 showed the most dramatic behavior: all four candidate microRNAs were significantly induced after treatment, yet the induced miR-34a-5p and miR-26a-5p still failed to reach control-like levels. AT5849 showed only a significant reduction of miR-106b-5p, and AT9607 showed significant induction of miR-34a-5p alone. The response, in short, was heterogeneous and cell-line specific rather than a uniform A-T signature.

To organize the biological context of the candidate panel, the team performed target-based enrichment analysis using DIANA-miRPath v4.0 with the experimentally validated miRTarBase 2022 interaction database, complemented by a sensitivity analysis with TarBase v8.0 and a network-based analysis with MIENTURNET visualized in Cytoscape. Across KEGG, Reactome, Gene Ontology and MSigDB Hallmark gene sets, the documented targets converged on cell-cycle regulation, G1/S transition, RB/E2F signaling, p53 signaling, apoptosis, senescence, PI3K-Akt and mTOR signaling, and DNA damage-associated processes. The network analysis identified ten genes connected to three of the four input microRNAs: CCND1, CCND2, E2F1, E2F3, MYC, PTEN, RB1, SMAD4, VEGFA and WEE1. The authors are careful to note that because the microRNAs were selected a priori for their known involvement in these pathways, the enrichment results annotate the predefined panel rather than independently validating the qPCR findings, and the network remains a hypothesis-generating framework rather than demonstrated regulation.

The mechanistic implications are nonetheless compelling. The persistent depletion of miR-34a-5p across all three A-T backgrounds fits squarely within the ATM-p53 checkpoint axis, since ATM is an upstream regulator of p53 activation and miR-34a is a direct p53-responsive tumor-suppressive microRNA. Importantly, the data support impaired normalization rather than complete absence of inducibility: some A-T lines retained miR-34a-5p inducibility after bleomycin but never reached control-like abundance, a nuance that distinguishes this work from earlier radiation studies in lymphocytes where the miR-34a response was not strongly discriminatory between A-T and control samples. The AT648-specific induction of miR-106b-5p and miR-20a-5p further nominates a p21/RB/E2F checkpoint hypothesis, because miR-106b family members can repress CDKN1A/p21, the major p53 effector of G1/S arrest, and miR-20a modulates E2F1, which intersects functionally with ATM-dependent p53 phosphorylation and apoptosis. Persistent depletion of miR-26a-5p, meanwhile, nominates WEE1, CHK1 and related checkpoint axes for validation.

The authors are equally explicit about the limitations that bound their conclusions. Only one ATM-proficient control line was included, and each A-T line represents a single donor, so donor-specific effects cannot be definitively separated from disease-associated ones. The sample size of three biological replicates per condition limits statistical power, no multiplicity correction was applied across the full set of comparisons, and a single endogenous normalizer, miR-16-5p, is less robust than a geometric mean of multiple validated references. Only one bleomycin dose and one 24-hour recovery time point were tested, mature microRNA abundance was measured without assessing pri-miRNA, AGO loading or target repression, and the database-derived candidate targets were not validated at the mRNA or protein level. Differences in immortalization and transformation status among the cell lines may also have shaped the line-specific responses.

What the study ultimately delivers is a checkpoint-centered model that is genuinely testable. A-T fibroblasts appear to carry a stable, shared depletion of selected ATM, p53 and DNA damage response-associated microRNAs, combined with cell-line-specific stress-induced remodeling of G1/S and RB/E2F-associated microRNA networks. The proposed next steps are concrete: measure p53 activation, p21, WEE1, CHK1, RB1, E2F1, E2F3, the cyclins, CDK6, BCL2, BCL2L11 and PTEN at mRNA and protein levels under the same conditions; prioritize the AT648 line for cell-cycle profiling after bleomycin; and, most decisively, restore miR-34a-5p or miR-26a-5p with mimic experiments to test whether candidate targets and checkpoint phenotypes shift in the expected direction. For a rare disease in which the non-coding RNA literature remains thin, this work provides a clear, mechanistically grounded map of where to look next, and a reminder that in A-T, microRNA biology is model-dependent, stimulus-dependent and time-dependent rather than reducible to any single signature.

Subject of Research: Dysregulation of DNA damage response-associated microRNAs in ataxia-telangiectasia fibroblasts

Article Title: DNA damage response associated miRNA dysregulation in Ataxia-telangiectasia

Article References: Iqbal, M. J., Bucci, C., Ricci, A., Morganti, G., Khan, F. I., Khan, M. J., & Menotta, M. (2026). DNA damage response associated miRNA dysregulation in Ataxia-telangiectasia. Molecular Biology Reports, 53(1), Article 1660. https://doi.org/10.1007/s11033-026-12860-1

Image Credits: AI Generated

DOI: 10.1007/s11033-026-12860-1

Keywords: ataxia-telangiectasia, ATM kinase, microRNA, DNA damage response, miR-34a-5p, miR-26a-5p, p53 signaling, bleomycin, cell-cycle checkpoint, RB/E2F, fibroblasts, genome instability

Loss of heterozygosity, or LOH, is a familiar concept in genetics. In a diploid organism, each gene normally exists in two copies, one inherited from each parent. Errors during mitosis, the process by which a cell duplicates and divides, can eliminate one of those copies, either through recombination, chromosome loss or segmental deletion. Previous work had established that mitotic errors alter the allelic composition of a gene roughly a thousand times more often than replication errors produce point mutations. This means that when selection favors the loss of a gene’s function, it will frequently be achieved by discarding the chromosome or chromosomal segment that carries it, rather than by mutating the gene itself. Aneuploidy, the state of having an abnormal number of chromosomes, is found in up to a quarter of newly isolated wild strains of Saccharomyces cerevisiae, a striking testament to how common these events are.

What remained unclear was whether complex rearrangements, those affecting multiple chromosomes at once, accumulate gradually through a series of independent steps or emerge suddenly in coordinated bursts. To find out, the team built an experimental system in which genome rearrangements could be generated de novo and their frequency, triggers, architecture and stability all measured. They compiled a list of 454 yeast genes whose deletion had been shown, in earlier screens using two well-established but distinct methods, one detecting gross chromosomal rearrangements and one detecting chromosome instability, to increase LOH. After accounting for strains that could not be manipulated successfully, 392 diploid deletion strains remained, each carrying a homozygous deletion of a different gene together with two heterozygous marker loci: CAN1 on the left arm of chromosome V and ade2::URA3 in the middle of the right arm of chromosome XV.

The researchers propagated 20 replicate mutation-accumulation cultures of each strain and plated cells onto selective media containing canavanine or 5-fluoroorotic acid, which only cells that had lost the functional allele at the corresponding marker could colonize. These assays yielded robust, strain-specific estimates of the single LOH rate per cell division, with 95 percent confidence limits typically spanning only a narrow range around the central value. A substantial majority of the deletion strains, 68 percent at the CAN1 locus and 82 percent at the URA3 locus, showed higher single LOH rates than the wild-type control, confirming that the mutations compiled from earlier qualitative screens indeed destabilize the genome in quantitative assays. The team then scored how frequently double mutants, resistant to both drugs simultaneously, appeared. Deletion strains varied enormously, and the most unstable strains under double selection were also among the most unstable under single selection, with a Spearman rank correlation of 0.61.

The critical question was whether these double events could be explained as two independent single events occurring in sequence. Because the experimental data alone could not distinguish one-step from two-step origins, the team turned to computer simulations. Using the empirically measured single LOH rates, they modeled mutation accumulation across colony growth, allowing cells to become single mutants at their measured rates and double mutants either sequentially or coincidentally at a rate equal to the product of the two single rates. Even under the deliberately conservative assumption that neither single nor double mutants paid any fitness penalty, an assumption that would maximize the survival and spread of sequentially derived double mutants, the simulated frequencies fell far short of what was observed. When fitness costs of 10 and 20 percent were applied, as is more realistic, the gap widened further. The observed double LOH frequencies exceeded the coincidental predictions by tens or even hundreds of times in the most unstable strains, and after subtracting the predicted sequential component, the residual coincidental events remained 26 times more frequent than expected.

What kinds of cellular defects produce such explosive instability? The answer emerged from Gene Ontology analysis of the deleted genes in the most unstable strains. Nearly half of the genes carry annotations related to cell cycle checkpoints, the surveillance mechanisms that halt progression through the division cycle when DNA is damaged or the mitotic spindle is improperly assembled. The checkpoint category as a whole is assigned to only 1.3 percent of all yeast genes, so its dominance among the strongest mutators is statistically striking. The remaining genes in the set are involved in DNA maintenance and repair, sister chromatid cohesion, and spindle formation, processes whose failure can generate damage so extensive that even intact checkpoints cannot contain it. The message is clear: genomes are most vulnerable to complex, multi-chromosome rearrangements when the checkpoints that police DNA integrity and spindle function fail to stop the cell cycle.

Direct examination of the double mutants themselves confirmed the picture. Flow cytometry of roughly 80 independent mutants from each of 43 highly unstable deletion strains revealed that DNA content was often substantially increased or decreased relative to the diploid ancestors, with the variance in DNA content among mutants significantly exceeding that among ancestral replicates. Whole-genome sequencing of mutants from 20 deletion strains went further. The dominant alteration was whole-chromosome aneuploidy, frequently affecting multiple chromosomes beyond the two targeted by selection, with many chromosomes showing non-integer coverage values that indicated mixed populations of cells carrying different chromosome counts. Averaged across all strains and chromosomes, deviations from diploidy appeared in nearly every mutant examined. Crucially, the chromosomes under direct selection, V and XV, showed no more than the average number of changes, evidence that selection at two sites was merely revealing systemic destabilization rather than focused local mutation. Heterozygous point mutations were rare, and the team found essentially no segmental copy number variants, no non-homologous recombination products and no convincing translocations or inversions in non-telomeric regions, despite deliberately validating that their pipelines could detect all such events.

Genetic tests of four particularly unstable strains, deleted for sem1, chl1, mre11 or rad27, provided independent confirmation. When double mutants from these strains were screened for retention of heterozygosity at two additional marker loci on chromosomes II and XII, the frequencies of additional losses were extraordinarily high. In the sem1 background, for example, 16 of 61 double mutants had also lost heterozygosity on chromosome II and 14 on chromosome XII, with 7 losing both, even though such losses normally occur at a rate of only one to a few per ten thousand cell divisions. Triple and quadruple LOH events appeared at frequencies far beyond anything a sequential model could accommodate, reinforcing the conclusion that short periods of hyper-instability, rather than a string of independent accidents, generate these genomes.

The final experiments addressed what happens to these dramatically rearranged genomes over evolutionary time. The team propagated 63 mutant cultures derived from 21 deletion strains for 200 generations in batch culture and re-measured their DNA content. The result was a nearly uniform contraction toward diploidy: strains that started far from two chromosome sets moved markedly closer, and the most divergent isolates showed the greatest fitness gains, growing faster after evolution than before. Aneuploidy, in other words, is typically a transient state, imposed as a cost of rapid adaptation and then pruned by natural selection as faster-growing re-diploidized variants outcompete their unstable relatives. The authors suggest that this ephemerality is exactly why such bursts are so hard to catch in nature, since selection rapidly erases the evidence of a genomic episode.

The findings carry implications well beyond yeast. In free-living microbes, aneuploidy usually slows growth and is quickly eliminated, but it may pay off under multiple stresses, such as exposure to several toxins at once. In the somatic cells of multicellular organisms, the calculus is different. These cells are programmed not to divide, so there is no immediate growth cost to genome restructuring, and a loosening of the brakes on cell division can incidentally expose recessive alleles, a mechanism central to cancer, where the loss of the remaining wild-type copy of a tumor suppressor gene is the classic second hit. The study suggests that failures of cell cycle control may be a common source of the large-scale chromosomal changes that dismantle multiple adaptation barriers during tumor evolution. Complex genome change, on this view, rarely arrives as a leisurely accumulation of small steps; it tends to arrive as a burst, born of a momentarily failing control system, and natural selection then decides what, if anything, survives.

Subject of Research: Loss of heterozygosity and aneuploidy driven by cell cycle control defects in diploid budding yeast

Article Title: Burst of aneuploidy: a cost of adaptation driven by breakdown of cell cycle control

Article References: Pirog, A., Tutaj, H., Tomala, K., & Korona, R. (2026). Burst of aneuploidy: a cost of adaptation driven by breakdown of cell cycle control. Molecular Systems Biology, 22(8), 1292-1311. https://doi.org/10.1038/s44320-026-00217-6

Image Credits: AI Generated

DOI: 10.1038/s44320-026-00217-6

Keywords: aneuploidy, loss of heterozygosity, cell cycle checkpoints, Saccharomyces cerevisiae, genome instability, mitosis, chromosome segregation, DNA repair, mutation rate, experimental evolution, cancer, genome rearrangements

cGAS is part of the cGAS–STING pathway, one of the body’s major systems for recognizing abnormal DNA. Under normal conditions, DNA is largely confined to the nucleus and mitochondria. When DNA fragments appear in the cytoplasm, they can signal viral infection, DNA damage or the breakdown of cellular structures. cGAS binds this misplaced DNA and synthesizes the small messenger molecule cyclic GMP–AMP, commonly abbreviated cGAMP. cGAMP activates the adaptor protein STING, which then stimulates signaling cascades involving TBK1, interferon regulatory factors and nuclear factor kappa B. These pathways induce type I interferons and inflammatory genes that help cells respond to invading pathogens and genomic danger. The new research indicates that cGAS also has a less obvious role in preserving long-term cellular stability. Without it, cells may become increasingly vulnerable to the consequences of mobile genetic elements and the chronic inflammatory signals associated with aging.

The study’s central finding concerns LINE1, short for long interspersed nuclear element 1. LINE1 sequences are remnants of ancient retrotransposons that occupy a substantial fraction of the mammalian genome. Unlike most genomic fossils, some LINE1 copies retain the ability to produce RNA and, in certain circumstances, proteins required for their movement. A functional LINE1 element can be transcribed into RNA and translated into two principal proteins, ORF1p and ORF2p. ORF2p contains endonuclease and reverse-transcriptase activities, allowing the element to copy itself and insert a new DNA copy elsewhere in the genome. In healthy, differentiated cells, LINE1 activity is usually restrained by DNA methylation, repressive histone modifications and other layers of epigenetic control. The researchers found that cGAS deficiency is associated with derepression of these elements, meaning that LINE1 sequences become more transcriptionally active than they should be.

The reactivation of LINE1 provides several possible routes to cellular damage. Its RNA can accumulate in the cytoplasm and form RNA–DNA hybrids or other nucleic-acid structures that resemble material produced during infection. LINE1 proteins may also generate DNA breaks while attempting to insert new copies into the genome. Reverse transcription can create additional DNA intermediates, while failed or incomplete transposition may increase replication stress and compromise chromosome integrity. These events can activate innate immune pathways even when no virus is present. In this sense, derepressed LINE1 elements may act as an endogenous source of danger signals: genetic sequences inherited from ancient retroviral activity become capable of provoking antiviral-like inflammation when the systems that normally keep them silent fail.

The reported association between cGAS loss and inflammation is especially significant because inflammation is not simply a secondary feature of aging. Persistent, low-level inflammatory signaling—often called inflammaging—is thought to contribute to tissue degeneration, immune dysfunction and the progression of multiple age-related diseases. Acute inflammation is generally protective and temporary, but chronic activation can damage neighboring cells, alter metabolism and interfere with tissue repair. In cGAS-deficient mice, the increased activity of LINE1 elements may help explain why inflammatory programs remain switched on. Cytoplasmic nucleic acids generated by transposable-element activity could stimulate innate immune sensors, while DNA damage and cellular stress could reinforce the same response through parallel pathways. The result would be a self-amplifying cycle in which weakened genome control promotes inflammation, and inflammation further undermines cellular homeostasis.

The findings also challenge the idea that cGAS is exclusively an inflammatory accelerator. In cancer biology and infection research, cGAS is often discussed as a pathway that detects abnormal DNA and stimulates immune activation. That role can be beneficial when the trigger is a virus or a malignant cell, but excessive cGAS–STING activity can also contribute to inflammatory disease. The new work suggests that the protein’s impact depends heavily on context. In the absence of cGAS, cells may lose an important layer of surveillance or coordination that limits the consequences of transposable-element activity. At the same time, the immune system may still detect the molecular debris produced by damaged or stressed cells through other sensors. The biology therefore cannot be reduced to a simple equation in which more cGAS always means more inflammation and less cGAS always means less.

A key implication is that aging may involve the gradual failure of systems that normally contain ancient genetic parasites. LINE1 sequences are not external pathogens, but their biochemical behavior resembles that of retroviruses. They can produce RNA, encode reverse transcriptase and generate nucleic-acid intermediates capable of activating antiviral defenses. This resemblance has led scientists to investigate whether endogenous retroelements contribute to age-related inflammation. The study adds cGAS to that emerging framework by connecting an innate DNA-sensing protein with the epigenetic repression of LINE1. If the relationship is confirmed in additional models, it could help explain why older tissues often show both greater transposable-element expression and a persistent interferon signature. It may also clarify why genome instability and inflammation frequently appear together rather than as independent features of aging.

The mouse findings could eventually inform strategies aimed at preserving healthy aging, but they do not yet point to an immediate treatment. One possibility would be to suppress LINE1 expression or block the reverse-transcriptase activity needed for its propagation. Experimental research in other settings has examined whether nucleoside reverse-transcriptase inhibitors, drugs originally developed against retroviruses, can reduce retrotransposon-associated activity. Another approach would be to restore epigenetic silencing or selectively interrupt inflammatory signals generated by endogenous nucleic acids. Each strategy carries risks. Broad suppression of innate immunity could weaken antiviral and antitumor defenses, while indiscriminate epigenetic manipulation might affect thousands of genes. Because cGAS also participates in responses to infection and cancer, any intervention would need to distinguish harmful chronic signaling from protective acute activation.

The work also highlights why results from genetically modified mice must be interpreted carefully. A complete, lifelong absence of cGAS may produce effects that differ from the partial decline, altered regulation or tissue-specific dysfunction that occurs during natural human aging. Mice and humans also differ in their repeat-element landscapes, immune systems, lifespans and patterns of disease. The presence of increased LINE1 expression or inflammatory markers in cGAS-deficient animals does not by itself prove that LINE1 drives every feature of their premature aging phenotype. Establishing causality will require experiments that selectively reduce LINE1 activity in cGAS-deficient mice and determine whether tissue degeneration, inflammatory signaling and functional decline are rescued. Studies in human cells and aging tissues will be equally important, particularly to establish whether cGAS activity, LINE1 derepression and inflammaging are consistently linked.

Even with these limitations, the study presents a coherent molecular model for how the loss of a DNA-sensing pathway can influence aging far beyond classical immune defense. cGAS-deficient mice appear to enter a state in which the genome’s repetitive elements become less tightly controlled, endogenous retroelement products accumulate and inflammatory pathways respond as though cells were under continuous microbial attack. The research places mobile genetic elements at the intersection of epigenetic regulation, genome maintenance and innate immunity. It also reinforces a broader view of aging as a systems-level failure involving communication between DNA integrity, cellular surveillance and inflammation. By showing that the repression of LINE1 elements is associated with cGAS-dependent protection against premature aging, the findings open a new line of investigation into whether controlling the genome’s ancient mobile sequences could one day help preserve tissue function and reduce chronic inflammatory damage.

Subject of Research: The role of cGAS in aging, LINE1 retrotransposon regulation, genome stability and inflammation in mice.

Article Title: cGAS-deficient mice display premature aging associated with derepression of LINE1 elements and inflammation.

Article References: Martinez, J.C., Morandini, F., Rechsteiner, C. et al. cGAS-deficient mice display premature aging associated with derepression of LINE1 elements and inflammation. Nature Aging (2026). https://doi.org/10.1038/s43587-026-01206-y

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s43587-026-01206-y

Keywords: cGAS, premature aging, LINE1, retrotransposons, inflammaging, innate immunity, genome stability, inflammation, mice, DNA sensing